Proto Labs, Inc.
PRLB · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.50 | 0.02 | -1.17 |
| FCF Yield | 7.00% | 4.43% | 5.77% | 1.48% |
| EV / EBITDA | 14.61 | 14.15 | 10.01 | 16.82 |
| Quality | ||||
| ROIC | 1.93% | 2.39% | -13.47% | 3.80% |
| Gross Margin | 44.56% | 44.06% | 44.12% | 45.62% |
| Cash Conversion Ratio | 4.69 | 4.26 | -0.60 | 1.66 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.85% | 1.07% | 3.98% | 2.09% |
| Free Cash Flow Growth | 52.04% | 11.80% | 92.05% | -64.92% |
| Safety | ||||
| Net Debt / EBITDA | -1.40 | -1.18 | -0.53 | -0.72 |
| Interest Coverage | 99.56 | 25.61 | -0.78 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 22.57 | 20.64 | 20.10 | 20.17 |
| Cash Conversion Cycle | 46.37 | 51.82 | 54.93 | 44.07 |